Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02891161
Brief Title: Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder (DUART)

First Submitted : September 1, 2016
First Submitted that Met QC Criteria : September 1, 2016
First Posted : September 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 5, 2021
Last Update Posted : February 8, 2021